Choosing the Right Preclinical Development Partner for Grant Programs

Small businesses in the United States are afforded the opportunity to develop technological or scientific innovations through grant programs such as the SBIR, STTR, DOD, and NSF. These highly competitive programs are one of the largest sources of capital for funding promising, early-stage technology that could be considered to be too risky for private investors. These funding mechanisms encourage small businesses to engage in research and development that has the potential for commercialization.

A sample of federal agencies with extramural research and development budgets participating in these grant programs include the:

  • Department of Agriculture
  • Department of Health and Human Services
  • National Aeronautics and Space Administration
  • National Science Foundation

Business entities that do not have the infrastructure and/or resources to carry out the research proposed in the grant application will need to identify a research partner or contract research organization in order to complete those tasks within their specified budget and timeline.

Experienced and Capable Preclinical Organization

Noble Life Sciences is a full-service preclinical contract research organization offering standard GLP and non-GLP services, including safety and efficacy testing for the development of drugs, vaccines, and medical devices. We offer preclinical testing in a wide variety of traditional and specialized animal models and are experienced with mice, rats, cotton rats, hamsters, gerbils, guinea pigs, rabbits, ferrets, sheep, goats, domestic swine, and mini pigs.

Our services include pharmacology, disease models, early safety assessments, toxicology, and GLP custom polyclonal antibodies. We are experienced in model transfer and the optimization of custom in-vivo and in-vitro specialized models to test and validate your therapeutic and/or device. Noble’s team of scientists implement effective and efficient approaches to help guide your research and development programs, including those specific to federal grant programs.

Grant-Friendly Preclinical CRO

Noble’s uniquely flexible business model enables us to work within your budget requirements and provide fast acting responses to meet your timelines. We have extensive experience with transitioning research projects from academic labs/early stage companies and carry out the projects with rigorous documentation to meet regulatory standards. In addition, our facility has AAALAC accreditation, OLAW assurance, USDA license, and an efficient IACUC review process to satisfy all your regulatory needs.

Furthermore, our facility operates with strict confidentiality policies to protect client proprietary information. We conduct our operations with stringent adherence to an extensive set of standard operating procedures that cover all aspects of animal care, animal procedures, equipment operation, and facility operation. We have more than 15 years of experience contracting with vaccine, medical device, and pharmaceutical companies to meet their needs from discovery to GLP preclinical studies for submission, including design and regulatory support.

For more information on why Noble Life Sciences is the right preclinical development partner for federal grant programs, contact us today.

2018-04-26T08:33:15+00:00April 20th, 2018|Blog|